4//SEC Filing
Weinberg Uri 4
Accession 0001645113-23-000029
CIK 0001645113other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:58 PM ET
Size
7.1 KB
Accession
0001645113-23-000029
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Weinberg Uri
Chief Innovation Officer
Transactions
- Award
Options to Buy Ordinary Shares
2023-02-28$76.97/sh+21,607$1,663,091→ 21,607 totalExercise: $76.97From: 2024-02-28Exp: 2033-02-27→ Ordinary Shares (21,607 underlying) - Award
Ordinary Shares
2023-02-28+12,992→ 56,278 total
Footnotes (2)
- [F1]Represents restricted share units that are scheduled to vest on February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
- [F2]Options to buy 21,607 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001811030
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:58 PM ET
- Size
- 7.1 KB